Physiology of growth hormone [online] 2006
The incidence tends to be higher in patients taking doses above 1.0 mg weekly
These are favorable odds for a relatively low-risk intervention, but they underscore that peptide therapy does not work for everyone
There are five types of melanocortin receptors, MC1R, MC@R, MC3R, MC4R and MC5R
Research has shown that the risk of semaglutide causing hypoglycemia may be low due to its insulinogenic effects being glucose-dependent
For more information about Novo Nordisk's efforts to protect patients and ensure access to safe, effective FDA-approved treatments, visit semaglutide.com About Novo Nordisk Novo Nordisk is a leading global healthcare company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years